MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience.

No Thumbnail Available
Authors
Rauch, A.
Cazzato, R. L.
Garnon, J.
Shaygi, Behnam
Tsoumakidou, G.
Caudrelier, J.
Bauones, S.
Koch, G.
Lipsker, D.
Gangi, A.
Journal
Cardiovascular and interventional radiology
Type
Journal Article
Publisher
Springer
Rights
Archived with thanks to Cardiovascular and interventional radiology
This study aims to discuss MRI-guided cryoablation (CA) of in-transit (IT) metastases from melanoma and to retrospectively present our preliminary experience in such a specific field. Three female patients (mean age 55.6 years; range 39-64) were included, and eight IT metastases (mean size 12.4 ± 6.5 mm, range: 5-25) were treated in three different sessions. Technical success was 100%; and mean procedural time 129.3 ± 103 min. (range 42-243). Primary local tumour control was 100% at 1-, 6- and 12-month follow-up; and 87.5% at 18-month follow-up. Two complications were recorded (one minor and one major). MRI-guided CA is a novel therapy, which may be included in the armamentarium of local therapies of IT metastases.
Citation
MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience. 2017 Aug;40(8):1285-1289
Note